1. Home
  2. SHOO vs VERA Comparison

SHOO vs VERA Comparison

Compare SHOO & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Steven Madden Ltd.

SHOO

Steven Madden Ltd.

HOLD

Current Price

$36.53

Market Cap

3.3B

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$43.85

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHOO
VERA
Founded
1990
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.4B
IPO Year
1993
2021

Fundamental Metrics

Financial Performance
Metric
SHOO
VERA
Price
$36.53
$43.85
Analyst Decision
Buy
Strong Buy
Analyst Count
8
11
Target Price
$42.75
$76.60
AVG Volume (30 Days)
1.6M
1.1M
Earning Date
02-25-2026
02-25-2026
Dividend Yield
2.35%
N/A
EPS Growth
N/A
N/A
EPS
0.78
N/A
Revenue
$2,362,727,000.00
N/A
Revenue This Year
$13.06
N/A
Revenue Next Year
$12.67
N/A
P/E Ratio
$45.72
N/A
Revenue Growth
6.41
N/A
52 Week Low
$19.05
$18.53
52 Week High
$46.88
$56.05

Technical Indicators

Market Signals
Indicator
SHOO
VERA
Relative Strength Index (RSI) 33.10 45.55
Support Level $33.89 $40.87
Resistance Level $46.88 $45.51
Average True Range (ATR) 2.13 2.26
MACD -1.16 -0.50
Stochastic Oscillator 20.63 33.45

Price Performance

Historical Comparison
SHOO
VERA

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: